| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Commercial | SVP Commercial
1 company
McCourt Marion is an EVP Commercial at REGENERON PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $8.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,100 | $581.53 | $639,683.00 | -5.3% | +29.8% | +28.2% | |
| Jul 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,100 | $587.76 | $646,536.00 | -5.3% | +16.2% | +20.7% | |
| Jun 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,100 | $669.51 | $736,461.00 | -5.3% | -10.7% | +11.0% | |
| May 2, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,100 | $656.97 | $722,667.00 | -5.3% | -11.6% | +22.5% | |
| Apr 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,000 | $701.82 | $701,820.00 | -4.8% | -14.9% | +18.3% | |
| Mar 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,000 | $615.39 | $615,390.00 | -4.8% | +9.5% | +26.9% | |
| Feb 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,000 | $607.46 | $607,460.00 | -4.8% | +6.3% | +23.6% | |
| Jan 3, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,000 | $625.00 | $625,000.00 | -4.8% | +11.4% | +14.9% | |
| Dec 13, 2021 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sell | 344 | $653.12 | $224,673.28 | -1.7% | -0.6% | +13.2% | |
| Dec 1, 2021 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,000 | $639.13 | $639,130.00 | -5.5% | -3.7% | +20.7% |